$1.45 Billion is the total value of BRIDGER MANAGEMENT, LLC's 40 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LH | Sell | LABORATORY CORP AMER HLDGS | $77,658,000 | -22.0% | 663,004 | -17.7% | 5.37% | +63.1% |
| POST | Sell | POST HLDGS INC | $76,513,000 | -10.9% | 1,112,589 | -20.1% | 5.29% | +86.3% |
| AET | Sell | AETNA INC NEW | $62,926,000 | +3.5% | 560,087 | -0.3% | 4.35% | +116.5% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDadr | $59,320,000 | -52.0% | 1,108,574 | -41.1% | 4.10% | +0.4% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $50,273,000 | -29.8% | 390,016 | -36.0% | 3.48% | +46.7% |
| FB | Sell | FACEBOOK INCcl a | $47,990,000 | -3.3% | 420,598 | -11.3% | 3.32% | +102.1% |
| CNC | Sell | CENTENE CORP DEL | $37,593,000 | -56.7% | 610,566 | -53.8% | 2.60% | -9.5% |
| WCG | Sell | WELLCARE HEALTH PLANS INC | $30,469,000 | +5.1% | 328,503 | -11.4% | 2.11% | +119.8% |
| SGMS | Sell | SCIENTIFIC GAMES CORPcl a | $15,391,000 | -43.2% | 1,632,180 | -46.0% | 1.06% | +18.8% |
| LXRX | Sell | LEXICON PHARMACEUTICALS INC | $12,308,000 | -36.0% | 1,029,926 | -28.7% | 0.85% | +34.0% |
| CMRX | Exit | CHIMERIX INC | $0 | – | -841,898 | -100.0% | -0.25% | – |
| EXAS | Exit | EXACT SCIENCES CORP | $0 | – | -1,540,841 | -100.0% | -0.47% | – |
| SHPG | Exit | SHIRE PLCsponsored adr | $0 | – | -140,886 | -100.0% | -0.96% | – |
| DYAX | Exit | DYAX CORP | $0 | – | -982,413 | -100.0% | -1.22% | – |
| SPY | Exit | SPDR S&P 500 ETF TRcall | $0 | – | -7,286,800 | -100.0% | -49.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERISIGN INC | 40 | Q1 2023 | 5.2% |
| TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
| MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
| ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
| POST HLDGS INC | 33 | Q4 2022 | 6.1% |
| TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
| ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
| GODADDY INC | 28 | Q3 2023 | 8.9% |
| CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
| Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
| Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
| TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
| CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
| Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
| PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.